Radical Numerics says an AI-designed bacteriophage was given to a patient with a drug-resistant infection

Radical Numerics · Press release

Read the source (opens in a new tab)
What happened
Radical Numerics, a lab founded by members of the Evo and Evo 2 team, launched its Omnii-1 genome model and announced that researchers used it to design a bacteriophage given to a patient with a drug-resistant bacterial infection.
Key points
  • The company calls this "the first AI-designed phage given to a human patient"; a cocktail containing the phage "killed the patient's bacterial isolate in laboratory testing and was then administered at a clinical site under a physician compassionate use access."
  • It says it is developing Omnii for biodefense "because the same advances that make it possible to design medicines can also be used to engineer pathogens that existing detection methods may miss."
  • In testing, the company says, "the model identified AI-generated pathogen sequences that conventional screening tools missed."
Evidence
A company press release announcing the model and the treatment. It cites no peer-reviewed paper.
Uncertain
All claims are self-reported by Radical Numerics, which says it holds a "dual mandate" to advance biological intelligence and biosecurity. The release states no clinical outcome for the patient and offers no independent verification of the phage design or the screening-evasion finding.

See it in the latest record